Bilirubin Isomers During LED Phototherapy of Hyperbilirubinemic Neonates, Blue-green (~478 nm) Vs Blue

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2024 Sep 4

PMID 39232092

Authors

Finn Ebbesen

Poul H Madsen

Maria Rodrigo-Domingo

Mette L Donneborg

Affiliations

Soon will be listed here.

Abstract

Background: The clinical part of this randomized controlled trial concerning phototherapy of neonates with hyperbilirubinemia showed that the recommended blue-green LED light (≈478 nm) was 31% more efficient than standard blue LED light (≈459 nm) measured by the decline in total serum bilirubin. Lumirubin has biologic effects. The aim was to compare the serum bilirubin isomers, efficacy, and biologic effects between the two phototherapy groups.

Methods: Inclusion criteria: neonates healthy except for hyperbilirubinemia, gestational age ≥33 weeks, birth weight ≥1800 g, and postnatal age >24 h. Forty-two neonates were randomized to receive overhead blue-green light and 44 blue light. Treatment 24 h. The light irradiance was equal.

Results: The percentage decrease of combined bilirubin isomers was 47.8% for blue-green light vs 33.4% for blue light, the ratio being 1.43. Corresponding values for Z,Z-bilirubin were 55.6% vs 44.2%, the ratio being 1.26. The increase in the absolute serum concentrations of the photoisomer Z,E-bilirubin and thereby combined photoisomers were greater using blue light.

Conclusion: Blue-green light was essentially more efficient determined by the decline of combined bilirubin isomers and Z,Z-bilirubin itself. Regarding biological effects neonates receiving blue-green light might be more affected than neonates receiving blue light.

Impact: Phototherapy of hyperbilirubinemic neonates using blue-green LED light with a peak emission of 478 nm was 43% more efficient than standard blue LED light with a peak emission of 459 nm was measured by the decline of serum combined bilirubin isomers, and the decline of toxic Z,Z-bilirubin was 26% greater. Apparently, there was a discrepancy between the huge drop in total serum bilirubin and the low serum concentrations of E,Z-bilirubin and E,Z-lumirubin. This was caused by the rapid excretion of E,Z-lumirubin. Lumirubin has biologic effects. Due to greater lumirubin production neonates exposed to blue-green light might be more affected than those exposed to blue light.

References

Le Pichon J, Riordan S, Watchko J, Shapiro S . The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs). Curr Pediatr Rev. 2017; 13(3):199-209. DOI: 10.2174/1573396313666170815100214. View

Alken J, Hakansson S, Ekeus C, Gustafson P, Norman M . Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden. JAMA Netw Open. 2019; 2(3):e190858. PMC: 6583272. DOI: 10.1001/jamanetworkopen.2019.0858. View

Hansen T, Jeffrey Maisels M, Ebbesen F, Vreman H, Stevenson D, Wong R . Sixty years of phototherapy for neonatal jaundice - from serendipitous observation to standardized treatment and rescue for millions. J Perinatol. 2019; 40(2):180-193. DOI: 10.1038/s41372-019-0439-1. View

Ebbesen F, Madsen P, Stovring S, Hundborg H, Agati G . Therapeutic effect of turquoise versus blue light with equal irradiance in preterm infants with jaundice. Acta Paediatr. 2007; 96(6):837-41. DOI: 10.1111/j.1651-2227.2007.00261.x. View

Ebbesen F, Vandborg P, Madsen P, Trydal T, Jakobsen L, Vreman H . Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates. Pediatr Res. 2015; 79(2):308-12. DOI: 10.1038/pr.2015.209. View

Ebbesen F, Rodrigo-Domingo M, Moeller A, Vreman H, Donneborg M . Effect of blue LED phototherapy centered at 478 nm versus 459 nm in hyperbilirubinemic neonates: a randomized study. Pediatr Res. 2020; 89(3):598-603. DOI: 10.1038/s41390-020-0911-9. View

Doumas B, Perry B, Jendrzejczak B, MCCOMB R, Schaffer R, Hause L . Candidate reference method for determination of total bilirubin in serum: development and validation. Clin Chem. 1985; 31(11):1779-89. View

Ebbesen F, Donneborg M, Vandborg P, Vreman H . Action spectrum of phototherapy in hyperbilirubinemic neonates. Pediatr Res. 2021; 92(3):816-821. DOI: 10.1038/s41390-021-01743-9. View

Lamola A, Bhutani V, Wong R, Stevenson D, McDonagh A . The effect of hematocrit on the efficacy of phototherapy for neonatal jaundice. Pediatr Res. 2013; 74(1):54-60. DOI: 10.1038/pr.2013.67. View

10.

Lamola A . A Pharmacologic View of Phototherapy. Clin Perinatol. 2016; 43(2):259-76. DOI: 10.1016/j.clp.2016.01.004. View

11.

Ebbesen F, Madsen P, Vandborg P, Jakobsen L, Trydal T, Vreman H . Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue). Pediatr Res. 2016; 80(4):511-5. DOI: 10.1038/pr.2016.115. View

12.

McDonagh A . Controversies in bilirubin biochemistry and their clinical relevance. Semin Fetal Neonatal Med. 2009; 15(3):141-7. DOI: 10.1016/j.siny.2009.10.005. View

13.

Onishi S, Isobe K, Itoh S, Manabe M, Sasaki K, Fukuzaki R . Metabolism of bilirubin and its photoisomers in newborn infants during phototherapy. J Biochem. 1986; 100(3):789-95. DOI: 10.1093/oxfordjournals.jbchem.a121772. View

14.

Vreman H, Kourula S, Jasprova J, Ludvikova L, Klan P, Muchova L . The effect of light wavelength on in vitro bilirubin photodegradation and photoisomer production. Pediatr Res. 2019; 85(6):865-873. DOI: 10.1038/s41390-019-0310-2. View

15.

McDonagh A, Agati G, Fusi F, Pratesi R . Quantum yields for laser photocyclization of bilirubin in the presence of human serum albumin. Dependence of quantum yield on excitation wavelength. Photochem Photobiol. 1989; 50(3):305-19. DOI: 10.1111/j.1751-1097.1989.tb04164.x. View

16.

Greenberg J, Malhotra V, Ennever J . Wavelength dependence of the quantum yield for the structural isomerization of bilirubin. Photochem Photobiol. 1987; 46(4):453-6. DOI: 10.1111/j.1751-1097.1987.tb04794.x. View

17.

Okada H, Masuya K, Yasuda S, Okubo K, Kawada K, Kusaka T . Developmental changes in serum half-life of (EZ)-cyclobilirubin. Early Hum Dev. 2005; 81(7):619-22. DOI: 10.1016/j.earlhumdev.2005.03.014. View

18.

Ennever J, Knox I, Denne S, Speck W . Phototherapy for neonatal jaundice: in vivo clearance of bilirubin photoproducts. Pediatr Res. 1985; 19(2):205-8. DOI: 10.1203/00006450-198502000-00012. View

19.

Mreihil K, McDonagh A, Nakstad B, Hansen T . Early isomerization of bilirubin in phototherapy of neonatal jaundice. Pediatr Res. 2010; 67(6):656-9. DOI: 10.1203/PDR.0b013e3181dcedc0. View

20.

Mreihil K, Madsen P, Nakstad B, Saltyte Benth J, Ebbesen F, Hansen T . Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double fluorescent lamps vs. photodiodes. Pediatr Res. 2015; 78(1):56-62. DOI: 10.1038/pr.2015.61. View